关于“慢性阻塞性肺疾病药物治疗成本与全球慢性阻塞性肺疾病倡议指南（2007年、2011年及2017年更新版）变化的关系”的述评 - Suppr | 超能文献

Commentary on "Costs of pharmacotherapy of chronic obstructive pulmonary disease in relation to changing Global Initiative for Chronic Obstructive Lung Disease guidelines (2007, 2011, and 2017 updates)".

作者信息

Braido Fulvio

出版信息

Pol Arch Intern Med. 2019 May 31;129(5):299-300. doi: 10.20452/pamw.14856.

DOI:10.20452/pamw.14856

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Commentary on "Costs of pharmacotherapy of chronic obstructive pulmonary disease in relation to changing Global Initiative for Chronic Obstructive Lung Disease guidelines (2007, 2011, and 2017 updates)".关于“慢性阻塞性肺疾病药物治疗成本与全球慢性阻塞性肺疾病倡议指南（2007年、2011年及2017年更新版）变化的关系”的述评

Pol Arch Intern Med. 2019 May 31;129(5):299-300. doi: 10.20452/pamw.14856.

2

Costs of chronic obstructive pulmonary disease in relation to compliance with guidelines: a study in the primary care setting.慢性阻塞性肺疾病相关成本与指南依从性：初级保健环境中的一项研究。

Ther Adv Respir Dis. 2013 Jun;7(3):139-50. doi: 10.1177/1753465813484080. Epub 2013 May 7.

3

Severe chronic obstructive pulmonary disease.重度慢性阻塞性肺疾病

Clin Rev Allergy Immunol. 2003 Oct;25(2):151-63. doi: 10.1385/CRIAI:25:2:151.

4

Guideline for the management of chronic obstructive pulmonary disease--2011 update.慢性阻塞性肺疾病管理指南——2011 年更新版。

S Afr Med J. 2011 Jan;101(1 Pt 2):63-73.

5

Outpatient Chronic Obstructive Pulmonary Disease Management: Going for the GOLD.门诊慢性阻塞性肺疾病管理：追求 GOLD。

J Allergy Clin Immunol Pract. 2015 Jul-Aug;3(4):471-8; quiz 479-80. doi: 10.1016/j.jaip.2015.04.010.

6

Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines for chronic obstructive pulmonary disease.慢性阻塞性肺疾病全球倡议（GOLD）慢性阻塞性肺疾病指南。

Curr Opin Pulm Med. 2002 Mar;8(2):81-6. doi: 10.1097/00063198-200203000-00001.

7

Comparison of the 2017 and 2015 Global Initiative for Chronic Obstructive Lung Disease Reports. Impact on Grouping and Outcomes.2017 年和 2015 年全球慢性阻塞性肺疾病倡议报告比较。对分组和结果的影响。

Am J Respir Crit Care Med. 2018 Feb 15;197(4):463-469. doi: 10.1164/rccm.201707-1363OC.

8

Global Initiative for Chronic Obstructive Lung Disease 2017 Classification and Lung Function Decline in Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病全球倡议2017年慢性阻塞性肺疾病分类与肺功能下降

Am J Respir Crit Care Med. 2018 Mar 1;197(5):670-673. doi: 10.1164/rccm.201706-1154LE.

9

Spirometric Criteria for Chronic Obstructive Pulmonary Disease in Clinical Trials of Pharmacotherapy.药物治疗临床试验中慢性阻塞性肺疾病的肺量计标准

COPD. 2018 Feb;15(1):17-20. doi: 10.1080/15412555.2018.1424815.

10

Classification of patients with chronic obstructive pulmonary disease according to the Latin American Thoracic Association (ALAT) staging systems and the global initiative for chronic obstructive pulmonary disease (GOLD).根据拉丁美洲胸科学会（ALAT）分期系统和全球慢性阻塞性肺疾病倡议（GOLD）对慢性阻塞性肺疾病患者进行分类。

Arch Bronconeumol. 2017 Mar;53(3):98-106. doi: 10.1016/j.arbres.2016.08.015. Epub 2016 Dec 10.

引用本文的文献

1

A randomized controlled trial for prevention of acute exacerbation of stable chronic obstructive pulmonary disease with acupoint application of traditional Chinese medicine: Study protocol clinical trial (SPIRIT Compliant).一项关于中药穴位贴敷预防稳定期慢性阻塞性肺疾病急性加重的随机对照试验：研究方案临床试验（符合SPIRIT标准）

Medicine (Baltimore). 2020 Mar;99(10):e19396. doi: 10.1097/MD.0000000000019396.